Clinical Trials Browser

Completed × Carcinoma, Small Cell × BI 2536 × Clear all

NCT00412880 2022-06-22

BI 2536 Second Line Monotherapy in SCLC

Phase 2 Completed

23 enrolled 10 charts

Carcinoma, Small Cell